SEC Form 4 · accession 0001213900-26-067505
InMed Pharmaceuticals Inc. · INM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Vivo Opportunity, LLC
10% Owner
Vivo Opportunity Cayman Fund, L.P.
10% Owner
Vivo Opportunity Cayman, LLC
10% Owner
Vivo Opportunity Fund Holdings, L.P.
10% Owner
Period of report
May 20, 2026
Accepted (ET)
Jun 10, 2026 · 9:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001728328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF3,F1 | May 20, 2026 | P | 51,056 | $1.56 | A | 543,129 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF3,F2 | May 20, 2026 | P | 5,154 | $1.56 | A | 54,833 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF4,F1 | May 21, 2026 | P | 30,882 | $1.69 | A | 574,011 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF4,F2 | May 21, 2026 | P | 3,118 | $1.69 | A | 57,951 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF5,F1 | May 29, 2026 | P | 16,164 | $1.57 | A | 590,175 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF5,F2 | May 29, 2026 | P | 1,632 | $1.57 | A | 59,583 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF6,F1 | Jun 1, 2026 | P | 14,838 | $1.55 | A | 605,013 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF6,F2 | Jun 1, 2026 | P | 1,498 | $1.55 | A | 61,081 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF7,F1 | Jun 2, 2026 | P | 20,753 | $1.52 | A | 625,766 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF7,F2 | Jun 2, 2026 | P | 2,095 | $1.52 | A | 63,176 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF8,F1 | Jun 3, 2026 | P | 7,069 | $1.55 | A | 632,835 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF8,F2 | Jun 3, 2026 | P | 714 | $1.55 | A | 63,890 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF9,F1 | Jun 4, 2026 | P | 6,125 | $1.57 | A | 638,960 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF9,F2 | Jun 4, 2026 | P | 618 | $1.57 | A | 64,508 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF10,F1 | Jun 5, 2026 | P | 49,966 | $1.57 | A | 688,926 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF10,F2 | Jun 5, 2026 | P | 5,045 | $1.57 | A | 69,553 | I | By Vivo Opportunity Cayman Fund, L.P. |
| Common SharesF11,F1 | Jun 8, 2026 | P | 29,518 | $1.52 | A | 718,444 | I | By Vivo Opportunity Fund Holdings, L.P. |
| Common SharesF11,F2 | Jun 8, 2026 | P | 2,982 | $1.52 | A | 72,535 | I | By Vivo Opportunity Cayman Fund, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F10The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.53 to $1.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (10) to this Form 4.
- F11The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.48 to $1.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (11) to this Form 4.
- F2Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F3The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.42 to $1.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.
- F4The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.53 to $1.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.
- F5The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.55 to $1.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (5) to this Form 4.
- F6The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.49 to $1.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (6) to this Form 4.
- F7The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.49 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (7) to this Form 4.
- F8The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.50 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (8) to this Form 4.
- F9The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $1.55 to $1.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (9) to this Form 4.